It is an honour for us to have become part of this Alliance, which will certainly lead us to grow and learn a lot, both …
We are happy to announce that Mimesis has been chosen by the “Sole 24 ore”, a very important Italian newspaper, as an excellence in the field of medical-scientific research. Below is the article and the link to our video interview.https://aziende.publimediagroup.it/videointerviste-item/intervista-a-f-pappalardo-g-russo/
OMS World Patient Safety Day and Mimesis Srl: an interview. 17 September marks the 5th World Patient Safety Day (WPSD), promoted by the World Health …
Mimesis Srl, a Sicilian start-up, spin-off of the University of Catania, is among the companies selected to join the SMAU event in Milan on October 11 and 12.
The roadshow, repeated every year since 1964, brings together the best Italian and international start-ups that stand out for innovation and sustainability.
Mimesis thus completes the shortlist of participating companies in the Health and Wellness sector.
The objective of Mimesis is to propose in silico solutions: through the use of a computational simulator, it is able to reproduce almost completely the reaction of the immune system in the presence not only of viruses, bacteria and tumours, but also of pharmacological treatments.
Professor Francesco Pappalardo and Dr Giulia Russo, founding partners of Mimesis, say they are pleased with this participation: “We are very happy to have the opportunity to take part in this event: it is an excellent showcase, which will allow Mimesis to be known not only in Italy, but also in the rest of the world.”
Here, the details of the event: https://www.smau.it/?gclid=CjwKCAjwm8WZBhBUEiwA178UnK0V36EojQBaTe5VeYqsOw1JT7FxZ9LfrJFy_EJuJLItEL1476881hoCUxoQAvD_BwE
